Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Parallel, Vehicle-Controlled Phase III Trial to Assess the Efficacy and Safety of Topical SR-T100 Gel in the Treatment of Patients With Actinic Keratosis

NCT01493921 is registered in ClinicalTrials.gov with G&E Herbal Biotechnology Co., LTD as lead sponsor.

NCT NCT01493921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01493921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Parallel, Vehicle-Controlled Phase III Trial to Assess the Efficacy and Safety of Topical SR-T100 Gel in the Treatment of Patients With Actinic Keratosis
Lead sponsor
G&E Herbal Biotechnology Co., LTD
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2011
Completion date
November 30, 2015
Enrollment
113 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis